Cough News and Research

RSS

First-quarter fiscal 2010 results announced by China Aoxing Pharmaceutical

China Aoxing Pharmaceutical Company, Inc., a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced financial and operational results for the three month ended September 30, 2009, or the first quarter of fiscal year 2010.

24 Nov 2009

Scientists identify factors behind chronic coughing

Scientists have revealed how environmental irritants such as air pollution and cigarette smoke cause people to cough, in research published today in the American Journal of Respiratory and Critical Care Medicine. The

24 Nov 2009

Questionnaire study reveals half of barn workers experience cough or other ailments

The estimated 4.6 million Americans involved in the equine industry may be at risk of developing respiratory symptoms due to poor air quality in horse barns, according to a questionnaire study undertaken earlier this year by investigators at Tufts University's Cummings School of Veterinary Medicine.

21 Nov 2009

High prevalence of asthma among children with H1N1

A new study on pediatric H1N1 influenza admissions has found that asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu.

19 Nov 2009

Binge drinking, cannabis and prescription drugs still remain a concern among teenagers

While fewer teens are drinking alcohol in 2009 than a decade ago, binge drinking, use of cannabis and prescription drugs remain a concern, according to the 2009 Ontario Student Drug Use and Health Survey (OSDUHS) released today by the Centre for Addiction and Mental Health.

19 Nov 2009

FDA issues complete response for Rituxan, a drug for treating chronic lymphocytic leukemia

Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) issued a complete response on the companies’ applications for Rituxan® (rituximab) plus fludarabine and cyclophosphamide (FC) for the treatment of people with previously untreated and previously treated chronic lymphocytic leukemia (CLL).

19 Nov 2009

GAVI Alliance drives down pentavalent vaccine costs, data shows

The "co-ordinated buying policy" of the GAVI Alliance has driven down "[t]he price of a vaccine that helps babies fight off killer diseases," according to data released by the group, Reuters reports. In 2010, the price of pentavalent vaccine, which protects against Hib (Haemophilus influenzae type b), diphtheria, whooping cough, tetanus and hepatitis B, will fall "below $3.0 - a drop of almost $0.50 cents per dose on the 2009 price," according to the news services.

19 Nov 2009

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

Millennium: The Takeda Oncology Company today announced it has further expanded its protein homeostasis program with the initiation of a Phase I clinical trial for an oral formulation of MLN9708, the Company’s second-generation proteasome inhibitor. An intravenous formulation of MLN9708 entered clinical trials in March.

18 Nov 2009

Tips on how to prevent household members from getting sick during flu season

someone at home who has H1N1 (swine) flu, it is important for you to prevent other people in the house from getting sick, according to Gary Kalkut, MD, MPH, Senior Vice-President, Chief Medical Officer of Montefiore Medical Center.

18 Nov 2009

AVMA confirms that a household cat in Iowa showed signs of H1N1 influenza

Amarillo Biosciences, Inc. reported that the American Veterinary Medical Association (AVMA) recently confirmed that a household cat in Iowa developed signs of respiratory infection caused by H1N1 influenza virus.

12 Nov 2009

FDA approves CSL Biotherapies' seasonal flu vaccine, Afluria for children

CSL Biotherapies, a subsidiary of CSL Limited, one of the world’s leading manufacturers of influenza vaccine, announced that the U.S. Food and Drug Administration (FDA) has approved the company’s application for accelerated approval of its seasonal flu vaccine, Afluria® (Influenza Virus Vaccine) for use in the pediatric population aged 6 months and older.

12 Nov 2009

Oregon state officials confirm that three more ferrets have tested positive for the 2009 H1N1 virus

Three more ferrets in Oregon have tested positive for the 2009 pandemic influenza H1N1 virus, state officials confirmed this afternoon, bringing the total number of cases affecting ferrets in the state to four.

12 Nov 2009

Majority of pharmacists say patients should use OTC drugs at the first sign of cold and flu symptoms

A recent national survey of 505 pharmacists found that nine out of 10 pharmacists believe it is important for a patient to seek treatment early to help shorten the duration and severity of a cold.

11 Nov 2009

New visitation guidelines to prevent novel flu spread

The New Jersey Hospital Association has issued new visitation guidelines for the state's hospitals to help them protect patients, staff and visitors from H1N1 influenza.

11 Nov 2009

School district leaders plan for H1N1 pandemics using a four-step process

School district leaders planning for H1N1 pandemics should update emergency plans using a four-step process, according to the McGraw-Hill Education Urban Advisory Resource, a team of former educators and school administrators dedicated to serving the unique needs of large school districts.

6 Nov 2009

SafetyTies and SafetyScarves of SafeSmart help reduce the spread of H1N1

According to the Centers for Disease Control (CDC), H1N1 - better known as the swine flu - was widespread in 48 states as of Oct. 18-24. The CDC's website offers guidelines, from cough etiquette to keeping sick workers at home, for healthcare professionals and the public on how to minimize spread of the H1N1 influenza.

5 Nov 2009

InterMune seeks FDA marketing approval for pirfenidone

InterMune, Inc. today announced that it has submitted an electronic New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Pirfenidone has been granted Orphan Drug and Fast Track designation by the FDA, and also has been granted Orphan Drug status in Europe.

5 Nov 2009

Department of Health urges healthcare professionals to be vaccinated against H1N1 flu

Saying healthcare workers are "on the front lines" of battling the H1N1 flu pandemic, the Department of Health today urged healthcare professionals across Pennsylvania to be vaccinated against the H1N1 flu.

4 Nov 2009

Hospitalization and death of H1N1 patients can occur at all ages, says study

In contrast with some common perceptions regarding 2009 influenza A(H1N1) infections, an examination of cases in California indicates that hospitalization and death can occur at all ages, and about 30 percent of hospitalized cases have been severe enough to require treatment in an intensive care unit, according to a study in the November 4 issue of JAMA.

4 Nov 2009

Five-year old Pennsylvanian boy dies of H1N1 flu complications

The Department of Health today confirmed that a five-year old Adams County boy died on Oct. 31 as a result of complications from H1N1 flu. This is Pennsylvania's first pediatric death associated with H1N1.

4 Nov 2009